Continuing Medical Education (CME) For Your Healthcare Team

Immune-Related Adverse Events with Cancer Immunotherapy: Case-Based Challenges for the Oncology Nurse

Click here to complete this activity
Precision Therapy in NSCLC: Pharmacist Perspectives on Testing Strategies and Biomarker-driven Treatment Approaches

Click here to complete this online activity
Pharmacist Perspectives: Exploring the Evolving Role of BTK Inhibitors in CLL

Click here to complete this online activity
Navigating a Changing Landscape in TNBC: Pharmacist-Focused Strategies in the Era of Immunotherapy

Click here to complete this online activity
New Horizons in HER2+ Breast Cancer: Pharmacist-Focused Strategies and Insights

Click here to complete this online activity
A New Frontier in Cancer Therapy: Examining the Role of PARP Inhibitors in an Emerging Paradigm

Complete Activity
Exploiting Deficiencies in the Tumor Genome: Expert Perspectives in the Era of PARP Inhibitors

Complete Activity
The Changing Face of Lung Cancer: Exploring Recent Advances in Precision Medicine for EGFR-Mutated NSCLC

Complete Activity
Immune-Related Adverse Events with Cancer Immunotherapy: Case-Based Challenges for the Oncology Nurse

For more information on the regional chapter series click here
EGFR Resisters Inaugural Think Tank Proceedings and Call to Action

To read the proceedings and call to action click here
The Changing Face of Lung Cancer: Exploring Recent Advances in Precision Medicine for EGFR-Mutated NSCLC

For more information on the regional chapter series click here
B-Cell Malignancies Tumor Board: Therapeutic Decision Making in Challenging Clinical Scenarios (Regional Chapters)

For more information on regional chapters click here
Expert Perspectives in The Era of PARP Inhibitors: Practical Applications for Your Ovarian Cancer Patients

For more information on the multi-modal grand rounds click here

HomeSpiderSavvy2018-09-18T12:08:25-04:00

Upcoming Events

Pharmacist Perspectives: Exploring the Evolving Role of BTK Inhibitors in CLL

April 13, 2020 - April 13, 2021

Navigating a Changing Landscape in TNBC: Pharmacist-Focused Strategies in the Era of Immunotherapy

April 13, 2020 - April 13, 2021

Precision Therapy in NSCLC: Pharmacist Perspectives on Testing Strategies and Biomarker-Driven Treatment Approaches

April 13, 2020 - April 13, 2021

New Horizons in HER2+ Breast Cancer: Pharmacist-Focused Strategies and Insights

April 13, 2020 - April 13, 2021

Immune-Related Adverse Events with Cancer Immunotherapy: Case-Based Challenges for the Oncology Nurse

Precision Therapy in NSCLC: Pharmacist Perspectives on Testing Strategies and Biomarker-driven Treatment Approaches

Pharmacist Perspectives: Exploring the Evolving Role of BTK Inhibitors in CLL

Navigating a Changing Landscape in TNBC: Pharmacist-Focused Strategies in the Era of Immunotherapy

New Horizons in HER2+ Breast Cancer: Pharmacist-Focused Strategies and Insights

A New Frontier in Cancer Therapy: Examining the Role of PARP Inhibitors in an Emerging Paradigm

Exploiting Deficiencies in the Tumor Genome: Expert Perspectives in the Era of PARP Inhibitors

The Changing Face of Lung Cancer: Exploring Recent Advances in Precision Medicine for EGFR-Mutated NSCLC

Immune-Related Adverse Events with Cancer Immunotherapy: Case-Based Challenges for the Oncology Nurse

EGFR Resisters Inaugural Think Tank Proceedings and Call to Action

The Changing Face of Lung Cancer: Exploring Recent Advances in Precision Medicine for EGFR-Mutated NSCLC

B-Cell Malignancies Tumor Board: Therapeutic Decision Making in Challenging Clinical Scenarios (Regional Chapters)

Expert Perspectives in The Era of PARP Inhibitors: Practical Applications for Your Ovarian Cancer Patients

Upcoming Events

Pharmacist Perspectives: Exploring the Evolving Role of BTK Inhibitors in CLL

April 13, 2020 - April 13, 2021

Navigating a Changing Landscape in TNBC: Pharmacist-Focused Strategies in the Era of Immunotherapy

April 13, 2020 - April 13, 2021

Precision Therapy in NSCLC: Pharmacist Perspectives on Testing Strategies and Biomarker-Driven Treatment Approaches

April 13, 2020 - April 13, 2021

New Horizons in HER2+ Breast Cancer: Pharmacist-Focused Strategies and Insights

April 13, 2020 - April 13, 2021